News
Results of Prophylactic Treatment of Severe von Willebrand Disease with Recombinant vWF
The phase III study cited below evaluated the efficacy and safety of 12-month prophylaxis with recombinant von Willebrand factor (rvWF) in 23 patients with severe von Willebrand disease (vWD), who had previously been treated either on-demand (during spontaneous bleeding episodes) or had been on prophylaxis with plasma-derived vWF (pdvWF).
The Brain, Too, Has Its Midlife Crisis. How Do These Changes Relate to the Risk of Dementia in Old Age?
The human brain undergoes rapid changes during certain developmental periods. Childhood,…
Excellent effect of sotorasib in a higher line of treatment in a patient with NSCLC with G12C mutation of KRAS – a case study
We present a case study of an elderly patient with non-small cell lung cancer (NSCLC) treated with…
Fluoroscopically Calibrated 3D-Printed Tools Increase Osteotomy Precision During Tumor Resection Near Joints
The area around the knee is a common site for malignant bone tumors, such as osteosarcomas. Their…
Intermittent Fasting May Carry Significant Health Risks
Results from an observational study presented at this year’s American Heart Association (AHA)…
Smaller Volume and Faster Infusion Rate of aPCC: What Do Current Data Say About This Modification?
Administering an infusion of activated prothrombin complex concentrate (aPCC) at the standardized rate...
Portal Vein Thrombosis as a Complication of COVID-19 Infection – A Case Study
COVID-19 Infection is Associated with a Higher Risk of Thrombotic Complications. Many cases of deep...
Experience with 20% subcutaneous immunoglobulin in the treatment of primary immunodeficiency
Patients with primary antibody deficiency are administered immunoglobulin (Ig) replacement therapy to...
The Benefit of Liposomal Irinotecan in the Treatment of Pancreatic Cancer in a Young Patient – A Case Study
Pancreatic tumors continue to be a challenge in modern oncology. Due to the asymptomatic nature of…
Each Missed Dose of Thromboprophylaxis in Trauma Patients Significantly Increases the Risk of VTE
Available data shows that enoxaparin prophylaxis effectively reduces the incidence of venous thromboembolism...